Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HIG1 hypoxia inducible domain family member 1A pseudogene 17 (HIGD1AP17) is a human pseudogene. Pseudogenes are non-functional segments of DNA that resemble genes but typically do not encode a functional protein. There are currently no established biological functions, disease roles, or known drug interactions for this pseudogene[4][5][8]. This "target" is not a therapeutic target but a pseudogene, as confirmed by multiple genome resources[4][5][7][8]. There is no evidence it codes for a protein or is involved in any molecular or biological processes relevant to therapeutics. If you require a functional member of the HIG1 hypoxia inducible domain family (e.g., HIGD1A), that would refer to an actual gene/protein target and not to a pseudogene[9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HIG1 hypoxia inducible domain family member 1A pseudogene 17 (HIGD1AP17).